Real-time enrollment status for this bipolar disorder clinical trial
Current Status
Completed
Checked: March 2, 2026 at 8:49 AM UTC
| NCT Number | NCT06605599 |
| Recruiting Status | Completed |
| Condition | Bipolar Disorder |
| Phase | Clinical Trial |
| Target Enrollment | 160 participants |
| Active Locations | 32 sites in the US |
| Sponsor | AbbVie |
| Last Updated on CT.gov | January 12, 2026 (Jan 12, 2026) |
As of March 2, 2026: Clinical trial NCT06605599 is currently completed participants. This clinical trial study for bipolar disorder is not currently accepting new participants at 32 locations across the United States. The study is sponsored by AbbVie. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT06605599 is currently completed. The study may resume recruiting in the future.
This trial is recruiting at 32 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06605599 was last updated Jan 12, 2026 (January 12, 2026). HelloStudys verifies this status automatically.